Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Sep;46(3):331–339. doi: 10.1038/bjc.1982.208

Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome.

W M Melia, H B Nunnerley, P J Johnson, R Williams
PMCID: PMC2011132  PMID: 6181801

Abstract

Thirty patients with symptoms of the carcinoid syndrome and other symptoms not controlled by pharmacological agents were analysed with respect to the value of various treatment measures used. Tumour devascularization was carried out in 11 patients, either by surgical ligation of the main hepatic artery (6) or by percutaneous arterial embolization (5). The latter was shown to be the safer technique, both with respect to initial morbidity/mortality and other side effects. Control of flushing and diarrhoea was achieved in 80% and the technique was also repeated on one occasion with success when symptoms recurred. The use of cytotoxic drugs alone, including 5-fluorouracil, cyclophosphamide and Adriamycin produced symptomatic relief in only 4 of the 22 patients treated. They should only be considered if devascularization by arterial embolization proves impossible or cannot be repeated when symptoms recur.

Full text

PDF
331

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison D. J., Modlin I. M., Jenkins W. J. Treatment of carcinoid liver metastases by hepatic-artery embolisation. Lancet. 1977 Dec 24;2(8052-8053):1323–1325. doi: 10.1016/s0140-6736(77)90369-5. [DOI] [PubMed] [Google Scholar]
  2. Chernicoff D., Bukowski R. M., Groppe C. W., Jr, Hewlett J. S. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin. Cancer Treat Rep. 1979 May;63(5):795–796. [PubMed] [Google Scholar]
  3. Davis Z., Moertel C. G., McIlrath D. C. The malignant carcinoid syndrome. Surg Gynecol Obstet. 1973 Oct;137(4):637–644. [PubMed] [Google Scholar]
  4. Engelman K., Lovenberg W., Sjoerdsma A. Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome. N Engl J Med. 1967 Nov 23;277(21):1103–1108. doi: 10.1056/NEJM196711232772101. [DOI] [PubMed] [Google Scholar]
  5. Legha S. S., Valdivieso M., Nelson R. S., Benjamin R. S., Bodey G. P. Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literature. Cancer Treat Rep. 1977 Dec;61(9):1699–1703. [PubMed] [Google Scholar]
  6. Moertel C. G. Clinical management of advanced gastrointestinal cancer. Cancer. 1975 Aug;36(2):675–682. doi: 10.1002/1097-0142(197508)36:2+<675::aid-cncr2820360810>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  7. Murray-Lyon I. M., Parsons V. A., Blendis L. M., Dawson J. L., Rake M. O., Laws J. W., Williams R. Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs. Lancet. 1970 Jul 25;2(7665):172–175. doi: 10.1016/s0140-6736(70)92533-x. [DOI] [PubMed] [Google Scholar]
  8. PEART W. S., ROBERTSON J. I. The effect of a serotonin antagonist (UML 491) in carcinoid disease. Lancet. 1961 Nov 25;2(7213):1172–1174. doi: 10.1016/s0140-6736(61)90846-7. [DOI] [PubMed] [Google Scholar]
  9. Schein P. S., O'Connell M. J., Blom J., Hubbard S., Magrath I. T., Bergevin P., Wiernik P. H., Ziegler J. L., DeVita V. T. Clinical antitumor activity and toxicity of streptozotocin (NSC-85998). Cancer. 1974 Oct;34(4):993–1000. doi: 10.1002/1097-0142(197410)34:4<993::aid-cncr2820340404>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  10. Siklos P. Surgical approaches and drug treatment in the carcinoid syndrome. Br Med J. 1978 Jul 22;2(6132):281–281. doi: 10.1136/bmj.2.6132.281-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Solomon A., Sonoda T., Patterson F. K. Response of metastatic malignant carcinoid tumor to adriamycin (NSC-123127). Cancer Treat Rep. 1976 Mar;60(3):273–276. [PubMed] [Google Scholar]
  12. Stathopoulos G. P., Karvountzis G. G., Yiotis J. Tamoxifen in carcinoid syndrome. N Engl J Med. 1981 Jul 2;305(1):52–52. doi: 10.1056/NEJM198107023050115. [DOI] [PubMed] [Google Scholar]
  13. Stephen J. L., Grahame-Smith D. G. Treatment of the carcinoid syndrome by local removal of hepatic metastases. Proc R Soc Med. 1972 May;65(5):444–445. doi: 10.1177/003591577206500505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Zeegen R., Rothwell-Jackson R., Sandler M. Massive hepatic resection for the carcinoid syndrome. Gut. 1969 Aug;10(8):617–622. doi: 10.1136/gut.10.8.617. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES